| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |